Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by GreenLight Biosciences
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
July 24, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
May 30, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
May 11, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
July 20, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences Releases Inaugural Sustainability Report
April 12, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
March 30, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
March 28, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
March 09, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
March 07, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy
March 01, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
February 01, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
January 09, 2023
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
November 09, 2022
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences to Participate in Upcoming Investor Conferences in November
November 07, 2022
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences announces realignment to focus on near-term value drivers
October 12, 2022
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
GreenLight Biosciences and Queensland University of Technology partner to tackle destructive fall armyworm using RNA
October 05, 2022
From
GreenLight Biosciences
Via
GlobeNewswire
Tickers
GRNA
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.